{"id":29596,"date":"2019-11-07T11:07:24","date_gmt":"2019-11-07T10:07:24","guid":{"rendered":"https:\/\/wordpress-783423-2671269.cloudwaysapps.com\/?p=29596"},"modified":"2025-01-29T13:56:29","modified_gmt":"2025-01-29T12:56:29","slug":"7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar","status":"publish","type":"post","link":"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/","title":{"rendered":"7. November 2019 | Willow Biosciences auf OTCQB\u00ae Venture Market handelbar"},"content":{"rendered":"<style> .zur\u00fcckbutton:before {display: inline-block; font-family: \"ETmodules\"; content: \"4a\"; color: #00225f; margin-right: 7px;} .zur\u00fcckbutton:hover:before {display: inline-block; font-family: \"ETmodules\"; content: \"4a\"; color: #d85710; margin-right: 7px;}<\/style>\n<h1>Corporate News<\/h1>\n<p><a class=\"zur\u00fcckbutton\" href=\"https:\/\/cometis.de\/veroeffentlichungsarchiv-willow-biosciences\">zum Archiv<\/a><\/p>\n<h1>Willow Biosciences auf OTCQB<sup>\u00ae<\/sup> Venture Market handelbar<\/h1>\n<p><strong>Calgary, Alberta &#8211; 7. November 2019 &#8211; <\/strong>Willow Biosciences Inc. (&#8222;Willow&#8220; oder das &#8222;Unternehmen&#8220;) (CSE:WLLW; OTCQB:CANSF) gibt bekannt, dass ihre Aktien seit dem 5. November 2019 f\u00fcr den Handel am OTCQB<sup>\u00ae<\/sup> Venture Market (das &#8222;OTCQB&#8220;) unter dem Symbol &#8222;CANSF&#8220; zugelassen sind. Die Notierung in den USA verschafft Willow Zugang zu einer breiteren Basis von US-amerikanischen und internationalen Privatanlegern sowie institutionellen Investoren und bietet den Anlegern einen verbesserten Zugang zu Unternehmensdaten, eine erh\u00f6hte Transparenz und h\u00f6here Liquidit\u00e4t. Die Kurse f\u00fcr das US-Symbol von Willow sind unter <a href=\"http:\/\/www.otcmarkets.com\/stock\/CANSF\/quote\">www.otcmarkets.com\/stock\/CANSF\/quote<\/a> einsehbar. Dar\u00fcber arbeitet Willow daran, einen Antrag auf DTC-Zulassung (Depository Trust Company) in den USA zu stellen.<\/p>\n<p>&#8222;Die Notierung an der OTCQB erm\u00f6glicht eine engere Zusammenarbeit mit unserer US-amerikanischen Investorenbasis. Auf dem Weg zum Scale-Up der Produktion von hochreinem, pharmazeutisch hochwertigem Cannabidiol (CBD) mit unserem Partner Noramco, Inc., freuen wir uns, US-Investoren eine einfach zug\u00e4ngliche Plattform f\u00fcr Investitionen in unser Unternehmen zu bieten&#8220;, kommentiert Trevor Peters, CEO von Willow.<\/p>\n<p>Die Aktien der Gesellschaft werden weiterhin an der kanadischen B\u00f6rse unter dem Symbol &#8222;WLLW&#8220; gehandelt.<\/p>\n<div class=\"leseprobe-archiv\"><a title=\"Beitrag als PDF\"href=\"https:\/\/cometis.de\/wp-content\/uploads\/2019\/11\/WLLW-Press-Release-Sep-6th.pdf\"\"target=\"_blank\" rel=\"noopener noreferrer\">Beitrag als PDF<\/a><\/div>\n<style> .leseprobe-archiv {color: #00225f !important; border-color: #00225f; position: relative; padding: 0.3em 1em; border: 1px solid; -webkit-border-radius: 3px; -moz-border-radius: 3px; border-radius: 3px; -webkit-transition: all 0.2s; -moz-transition: all 0.2s; transition: all 0.2s; padding:10px; width: 19%; text-align: center; margin-right: 10px; float:left;} .leseprobe-archiv:hover {background-color: #eee; border-color: #ffffff; cursor: pointer;}<\/style>\n","protected":false},"excerpt":{"rendered":"<p>Corporate News zum Archiv Willow Biosciences auf OTCQB\u00ae Venture Market handelbar Calgary, Alberta &#8211; 7. November 2019 &#8211; Willow Biosciences Inc. (&#8222;Willow&#8220; oder das &#8222;Unternehmen&#8220;) (CSE:WLLW; OTCQB:CANSF) gibt bekannt, dass ihre Aktien seit dem 5. November 2019 f\u00fcr den Handel am OTCQB\u00ae Venture Market (das &#8222;OTCQB&#8220;) unter dem Symbol &#8222;CANSF&#8220; zugelassen sind. Die Notierung in [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":98872,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[88,263],"tags":[248],"class_list":["post-29596","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-willow-corporate-news","tag-248"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.2 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>7. November 2019 | Willow Biosciences auf OTCQB\u00ae Venture Market handelbar - cometis AG<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"7. November 2019 | Willow Biosciences auf OTCQB\u00ae Venture Market handelbar\" \/>\n<meta property=\"og:description\" content=\"Corporate News zum Archiv Willow Biosciences auf OTCQB\u00ae Venture Market handelbar Calgary, Alberta &#8211; 7. November 2019 &#8211; Willow Biosciences Inc. (&#8222;Willow&#8220; oder das &#8222;Unternehmen&#8220;) (CSE:WLLW; OTCQB:CANSF) gibt bekannt, dass ihre Aktien seit dem 5. November 2019 f\u00fcr den Handel am OTCQB\u00ae Venture Market (das &#8222;OTCQB&#8220;) unter dem Symbol &#8222;CANSF&#8220; zugelassen sind. Die Notierung in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/\" \/>\n<meta property=\"og:site_name\" content=\"cometis AG\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-07T10:07:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-29T12:56:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cometis.de\/wp-content\/uploads\/2024\/12-old\/Cometis-Mobile-Logo-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"171\" \/>\n\t<meta property=\"og:image:height\" content=\"31\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Assistenz cometis AG\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Assistenz cometis AG\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\\\/\"},\"author\":{\"name\":\"Assistenz cometis AG\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/#\\\/schema\\\/person\\\/5359bae3178840cd846706150aa69cd1\"},\"headline\":\"7. November 2019 | Willow Biosciences auf OTCQB\u00ae Venture Market handelbar\",\"datePublished\":\"2019-11-07T10:07:24+00:00\",\"dateModified\":\"2025-01-29T12:56:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\\\/\"},\"wordCount\":202,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cometis.de\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/icon_newsroom.svg\",\"keywords\":[\"2019\"],\"articleSection\":[\"News\",\"willow Corporate News\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\\\/\",\"url\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\\\/\",\"name\":\"7. November 2019 | Willow Biosciences auf OTCQB\u00ae Venture Market handelbar - cometis AG\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cometis.de\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/icon_newsroom.svg\",\"datePublished\":\"2019-11-07T10:07:24+00:00\",\"dateModified\":\"2025-01-29T12:56:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cometis.de\\\/de\\\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cometis.de\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/icon_newsroom.svg\",\"contentUrl\":\"https:\\\/\\\/www.cometis.de\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/icon_newsroom.svg\",\"width\":172,\"height\":172},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/category\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"7. November 2019 | Willow Biosciences auf OTCQB\u00ae Venture Market handelbar\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/\",\"name\":\"cometis AG\",\"description\":\"Deutschlands f\u00fchrende Investor Relations Agentur\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/#organization\",\"name\":\"cometis AG\",\"alternateName\":\"Deutschlands f\u00fchrende Investor Relations Agentur\",\"url\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cometis.de\\\/wp-content\\\/uploads\\\/2024\\\/12-old\\\/Cometis-Mobile-Logo-1.png\",\"contentUrl\":\"https:\\\/\\\/www.cometis.de\\\/wp-content\\\/uploads\\\/2024\\\/12-old\\\/Cometis-Mobile-Logo-1.png\",\"width\":171,\"height\":31,\"caption\":\"cometis AG\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/cometis-ag\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/cometisAG\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/#\\\/schema\\\/person\\\/5359bae3178840cd846706150aa69cd1\",\"name\":\"Assistenz cometis AG\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/43da04bfaca4f56c43243bf29c1e464e0dbbc04dfd398bead7b5594ba02bcec9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/43da04bfaca4f56c43243bf29c1e464e0dbbc04dfd398bead7b5594ba02bcec9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/43da04bfaca4f56c43243bf29c1e464e0dbbc04dfd398bead7b5594ba02bcec9?s=96&d=mm&r=g\",\"caption\":\"Assistenz cometis AG\"},\"url\":\"https:\\\/\\\/www.cometis.de\\\/de\\\/author\\\/assistenz-cometis-ag\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"7. November 2019 | Willow Biosciences auf OTCQB\u00ae Venture Market handelbar - cometis AG","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/","og_locale":"de_DE","og_type":"article","og_title":"7. November 2019 | Willow Biosciences auf OTCQB\u00ae Venture Market handelbar","og_description":"Corporate News zum Archiv Willow Biosciences auf OTCQB\u00ae Venture Market handelbar Calgary, Alberta &#8211; 7. November 2019 &#8211; Willow Biosciences Inc. (&#8222;Willow&#8220; oder das &#8222;Unternehmen&#8220;) (CSE:WLLW; OTCQB:CANSF) gibt bekannt, dass ihre Aktien seit dem 5. November 2019 f\u00fcr den Handel am OTCQB\u00ae Venture Market (das &#8222;OTCQB&#8220;) unter dem Symbol &#8222;CANSF&#8220; zugelassen sind. Die Notierung in [&hellip;]","og_url":"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/","og_site_name":"cometis AG","article_published_time":"2019-11-07T10:07:24+00:00","article_modified_time":"2025-01-29T12:56:29+00:00","og_image":[{"width":171,"height":31,"url":"https:\/\/www.cometis.de\/wp-content\/uploads\/2024\/12-old\/Cometis-Mobile-Logo-1.png","type":"image\/png"}],"author":"Assistenz cometis AG","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"Assistenz cometis AG","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/#article","isPartOf":{"@id":"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/"},"author":{"name":"Assistenz cometis AG","@id":"https:\/\/www.cometis.de\/de\/#\/schema\/person\/5359bae3178840cd846706150aa69cd1"},"headline":"7. November 2019 | Willow Biosciences auf OTCQB\u00ae Venture Market handelbar","datePublished":"2019-11-07T10:07:24+00:00","dateModified":"2025-01-29T12:56:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/"},"wordCount":202,"publisher":{"@id":"https:\/\/www.cometis.de\/de\/#organization"},"image":{"@id":"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cometis.de\/wp-content\/uploads\/2022\/06\/icon_newsroom.svg","keywords":["2019"],"articleSection":["News","willow Corporate News"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/","url":"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/","name":"7. November 2019 | Willow Biosciences auf OTCQB\u00ae Venture Market handelbar - cometis AG","isPartOf":{"@id":"https:\/\/www.cometis.de\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/#primaryimage"},"image":{"@id":"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cometis.de\/wp-content\/uploads\/2022\/06\/icon_newsroom.svg","datePublished":"2019-11-07T10:07:24+00:00","dateModified":"2025-01-29T12:56:29+00:00","breadcrumb":{"@id":"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/#primaryimage","url":"https:\/\/www.cometis.de\/wp-content\/uploads\/2022\/06\/icon_newsroom.svg","contentUrl":"https:\/\/www.cometis.de\/wp-content\/uploads\/2022\/06\/icon_newsroom.svg","width":172,"height":172},{"@type":"BreadcrumbList","@id":"https:\/\/www.cometis.de\/de\/7-november-2019-willow-biosciences-auf-otcqb-venture-market-handelbar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cometis.de\/de\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.cometis.de\/de\/category\/news\/"},{"@type":"ListItem","position":3,"name":"7. November 2019 | Willow Biosciences auf OTCQB\u00ae Venture Market handelbar"}]},{"@type":"WebSite","@id":"https:\/\/www.cometis.de\/de\/#website","url":"https:\/\/www.cometis.de\/de\/","name":"cometis AG","description":"Deutschlands f\u00fchrende Investor Relations Agentur","publisher":{"@id":"https:\/\/www.cometis.de\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cometis.de\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.cometis.de\/de\/#organization","name":"cometis AG","alternateName":"Deutschlands f\u00fchrende Investor Relations Agentur","url":"https:\/\/www.cometis.de\/de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.cometis.de\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.cometis.de\/wp-content\/uploads\/2024\/12-old\/Cometis-Mobile-Logo-1.png","contentUrl":"https:\/\/www.cometis.de\/wp-content\/uploads\/2024\/12-old\/Cometis-Mobile-Logo-1.png","width":171,"height":31,"caption":"cometis AG"},"image":{"@id":"https:\/\/www.cometis.de\/de\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/cometis-ag\/","https:\/\/www.youtube.com\/user\/cometisAG"]},{"@type":"Person","@id":"https:\/\/www.cometis.de\/de\/#\/schema\/person\/5359bae3178840cd846706150aa69cd1","name":"Assistenz cometis AG","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/43da04bfaca4f56c43243bf29c1e464e0dbbc04dfd398bead7b5594ba02bcec9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/43da04bfaca4f56c43243bf29c1e464e0dbbc04dfd398bead7b5594ba02bcec9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/43da04bfaca4f56c43243bf29c1e464e0dbbc04dfd398bead7b5594ba02bcec9?s=96&d=mm&r=g","caption":"Assistenz cometis AG"},"url":"https:\/\/www.cometis.de\/de\/author\/assistenz-cometis-ag\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cometis.de\/de\/wp-json\/wp\/v2\/posts\/29596","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cometis.de\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cometis.de\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cometis.de\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cometis.de\/de\/wp-json\/wp\/v2\/comments?post=29596"}],"version-history":[{"count":0,"href":"https:\/\/www.cometis.de\/de\/wp-json\/wp\/v2\/posts\/29596\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cometis.de\/de\/wp-json\/wp\/v2\/media\/98872"}],"wp:attachment":[{"href":"https:\/\/www.cometis.de\/de\/wp-json\/wp\/v2\/media?parent=29596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cometis.de\/de\/wp-json\/wp\/v2\/categories?post=29596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cometis.de\/de\/wp-json\/wp\/v2\/tags?post=29596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}